Elicio Therapeutics, Inc. (ELTX)
2.41
-0.09
(-3.60%)
USD |
NASDAQ |
Sep 04, 16:00
2.425
+0.02
(+0.62%)
After-Hours: 20:00
Elicio Therapeutics SG&A Expense (TTM) : 14.23M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.23M |
| March 31, 2026 | 13.70M |
| December 31, 2025 | 12.81M |
| September 30, 2025 | 11.82M |
| June 30, 2025 | 11.95M |
| March 31, 2025 | 11.60M |
| December 31, 2024 | 12.93M |
| September 30, 2024 | 13.40M |
| June 30, 2024 | 13.77M |
| March 31, 2024 | 13.86M |
| December 31, 2023 | 13.86M |
| September 30, 2023 | 12.29M |
| June 30, 2023 | 9.962M |
| March 31, 2023 | 8.32M |
| Date | Value |
|---|---|
| December 31, 2022 | 8.505M |
| September 30, 2022 | 11.04M |
| June 30, 2022 | 13.79M |
| March 31, 2022 | 16.94M |
| December 31, 2021 | 18.49M |
| September 30, 2021 | 17.40M |
| June 30, 2021 | 19.45M |
| March 31, 2021 | 20.54M |
| December 31, 2020 | 17.99M |
| September 30, 2020 | 19.01M |
| June 30, 2020 | 13.03M |
| March 31, 2020 | 7.598M |
| December 31, 2019 | 4.143M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Precigen, Inc. | 84.93M |
| Agenus, Inc. | 38.48M |
| Amgen, Inc. | 7.019B |
| Anika Therapeutics, Inc. | 52.67M |
| BioCryst Pharmaceuticals, Inc. | 328.11M |